Advertisement

Diagnosing Puffy Fingers in the Rheumatic Patient

  • Kazuhiko TakeharaEmail author
Chapter

Abstract

Many rheumatic disorders and other conditions accompany the clinical feature of puffy fingers. This sign is mainly observed in the early stage of these disorders. The most representative disease of puffy fingers is systemic sclerosis (SSc). In many cases of limited cutaneous SSc (lcSSc), Raynaud’s phenomenon, puffy fingers, SSc abnormal capillaroscopic pattern, and SSc-specific antinuclear antibodies precede skin sclerosis. Among SSc-specific antinuclear antibodies, anticentromere antibody (ACA) is most frequently observed in early lcSSc.

In addition, anti-Th/To antibody is well known as a serological marker of SSc sine scleroderma patients who exhibit only puffy fingers without a tendency to exhibit sclerodactyly.

Anti-u1 RNP antibody is also detected in the patients with “mixed connective tissue disease (MCTD)” or “undifferentiated connective tissue syndrome (UCTS)” who exhibit puffy fingers. In the category of dermatomyositis, the patients with anti-aminoacyl-tRNA synthetase antibody syndrome (ARS syndrome) also exhibit Raynaud’s phenomenon and puffy fingers.

Moreover, puffy fingers can be observed in early rheumatoid arthritis (RA), SSc-like disorders, overlapping syndromes, erythema pernio, and other conditions including thyroiditis/hypothyroidism, acromegalia, and primary Raynaud’s disease. Thus, for differential diagnosis of puffy fingers, careful clinical observation and serological investigation are very important.

Keywords

Interstitial Lung Disease Systemic Sclerosis Nephrogenic Systemic Fibrosis Mixed Connective Tissue Disease Rheumatic Disorder 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Matucci-Cerinic M, Allanore Y, Czirjá L, et al. The challenge of early systemic sclerosis for the EULAR Scleroderma Trial and Research Group (EUSTAR) community. It is time to cut the Gordian knot and develop a prevention or rescue strategy. Ann Rheum Dis. 2009;68:1377–80.PubMedCrossRefGoogle Scholar
  2. 2.
    Takehara K, Soma Y, Igarashi A, et al. Longitudinal study of patients with anticentromere antibody. Dermatologica. 1991;181:202–6.CrossRefGoogle Scholar
  3. 3.
    Hamaguchi Y, Hasegawa M, Fujimoto M, et al. The clinical relevance of serum antinuclear antibodies in Japanese patients with systemic sclerosis. Br J Dermatol. 2008;158:487–95.PubMedCrossRefGoogle Scholar
  4. 4.
    Fischer A, Meehan RT, Feghali-Bostwick CA, et al. Unique characteristics of systemic sclerosis sine scleroderma-associated interstitial lung disease. Chest. 2006;130:976–81.PubMedCrossRefGoogle Scholar
  5. 5.
    Fischer A, Pfalzgraf FJ, Feghali-Bostwick CA, et al. Anti-th/to-positivity in a cohort of patients with idiopathic pulmonary fibrosis. J Rheumatol. 2006;33:1600–5.PubMedGoogle Scholar
  6. 6.
    Sharp GC, Irvin WS, Tan EM, et al. Mixed connective tissue disease–an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med. 1972;52:148–59.PubMedCrossRefGoogle Scholar
  7. 7.
    LeRoy EC, Maricq HR, Kahaleh MB. Undifferentiated connective tissue syndromes. Arthritis Rheum. 1980;23:341–3.PubMedCrossRefGoogle Scholar
  8. 8.
    Khurana A, Runge VM, Narayanan M, et al. Nephrogenic systemic fibrosis: a review of 6 cases temporally related to gadodiamide injection (omniscan). Invest Radiol. 2007;42:139–45.PubMedCrossRefGoogle Scholar
  9. 9.
    Targoff IN. Myositis specific autoantibodies. Curr Rheumatol Rep. 2006;8:196–203.PubMedCrossRefGoogle Scholar
  10. 10.
    Shidara K, Inoue E, Tanaka E, et al. Comparison of the second and third generation anti-cyclic citrullinated peptide antibody assays in the diagnosis of Japanese patients with rheumatoid arthritis. Rheumatol Int. 2010;31(5):617–22.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2014

Authors and Affiliations

  1. 1.Department of DermatologyKanazawa UniversityKanazawaJapan

Personalised recommendations